In the high-stakes environment of recreational sports, the bond between teammates is often forged through sweat, competition, and shared victories. For Tori Ashman, a mother and athlete, these bonds were originally intended to be a source of fitness and fun. However, when a diagnosis of Stage 1B invasive ductal carcinoma threatened to upend her life in February 2023, the court was replaced by the clinic, and her teammates became a literal lifeline.
Ashman’s journey highlights a critical intersection between women’s health, the necessity of early detection, and the profound impact of culturally competent support systems like Sharsheret and community-driven organizations like Mamanet. Her story serves as a blueprint for navigating a life-altering diagnosis through the power of collective strength.
The Main Facts: A Diagnosis Amidst a Supportive Infrastructure
Tori Ashman’s story is not merely one of medical intervention, but of social and emotional resilience. In February 2023, Ashman was diagnosed with Stage 1B invasive ductal carcinoma. While the diagnosis was a shock, it was the culmination of years of vigilant screening—a "subscription box" of biopsies and scans that Ashman had managed since she turned 40.
Two primary organizations played a pivotal role in her recovery:
- Mamanet: An international mothers’ cachibol (Newball) league that emphasizes community, sportsmanship, and mutual support. For Ashman, the league provided the physical and emotional camaraderie necessary to maintain her spirits.
- Sharsheret: A national non-profit organization that provides support to Jewish women and families facing breast and ovarian cancer. Sharsheret’s model of care includes peer support, genetic counseling, and practical resources tailored to the specific needs of the community.
The convergence of these two groups, alongside a dedicated family network, allowed Ashman to navigate the complexities of cancer treatment while maintaining a semblance of normalcy and hope.
Chronology: From the First Mammogram to the Final Serve
The Vigilance of the 40s
The timeline of Ashman’s journey began with a routine milestone: her 40th birthday mammogram. While many view the procedure as a bureaucratic necessity of aging, for Ashman, it became the start of a long-term medical saga. During her initial screening, technicians requested additional images—a moment Ashman initially met with humor, joking that her "boobs were photogenic."
However, the levity was short-lived. A fast-tracked call from her physician led to a series of scans, tests, and eventually a lumpectomy. Though the initial findings were not cancerous, they set a precedent for hyper-vigilance. For several years, Ashman lived in a cycle of mammograms, ultrasounds, and biopsies. This period of "watchful waiting" is common for many women, creating a state of chronic anxiety that necessitates a strong psychological support system.
The 2023 Diagnosis
In February 2023, the cycle of screenings yielded a definitive result: Stage 1B invasive ductal carcinoma. Unlike her previous scares, this was a clear call to action. Ashman’s first instinct was to contact Sharsheret. Having been aware of the organization’s reputation within the Jewish community, she sought a connection with women who understood the specific nuances of her diagnosis and her life stage.
The Treatment and Support Phase
Following her diagnosis, Ashman entered a grueling period of treatment. During this time, the "sisterhood" of Mamanet moved from the sidelines into the center of her life. The team, known for their coordinated warm-ups and competitive spirit, redirected their energy toward Ashman’s recovery. They organized a dedicated night of play in her honor, ensuring that while she was physically absent from the court, her presence was felt through messages, donations, and a constant stream of emotional support.
Supporting Data: The Power of Early Detection
Ashman’s survival and positive prognosis are directly attributable to early detection. According to the American Cancer Society, when breast cancer is detected early and is in the localized stage, the five-year relative survival rate is 99%.
Key Statistics and Context:
- Survival Rates: The 99% survival rate for early detection stands in stark contrast to cases where the cancer has metastasized to distant parts of the body, where the survival rate drops significantly.
- The Ashkenazi Connection: Sharsheret’s focus on the Jewish community is backed by medical data. Individuals of Ashkenazi Jewish descent have a 1 in 40 chance of carrying a BRCA1 or BRCA2 gene mutation—nearly ten times the rate of the general population. These mutations significantly increase the risk of developing breast and ovarian cancer.
- Sharsheret’s Reach: The organization has supported over 275,000 women and families across the United States. Their "Busy Box" program, which Ashman utilized, provides age-appropriate resources for children to help them understand a parent’s diagnosis, bridging the communication gap during a family crisis.
Official Responses and Organizational Impact
Representatives from the organizations involved emphasize that Ashman’s experience is a testament to the "wrap-around" care model.
Sharsheret’s Holistic Approach
Sharsheret does not merely provide medical information; they offer a "continuum of care." Their clinicians and staff members provide peer support that matches patients with survivors of similar ages and backgrounds.
"They don’t just answer your questions—they hold your hand through every scan, every test, every sleepless night," Ashman noted. This sentiment is echoed by Sharsheret’s leadership, who advocate for a model where emotional health is treated with the same urgency as physical health. The organization provides financial assistance, genetic counseling, and educational webinars to empower patients to make informed decisions about their care.
Mamanet: Community in Motion
Mamanet’s response to Ashman’s diagnosis reflects the league’s core philosophy. Originally founded in Israel and now a global movement, Mamanet is designed to empower mothers through sport.
"The same women who dive across the court to save a ball would also dive into my life to lift me up," Ashman explained. The league’s structure allows for a built-in support network that can be mobilized instantly. When a member is in crisis, the "team" mentality shifts from winning games to ensuring the well-being of the individual.
Implications: A Call for Proactive Health Management
Tori Ashman’s story carries significant implications for public health messaging and the role of community in modern medicine.
The Normalization of Screening
Ashman’s narrative serves as a powerful endorsement for regular mammography. By framing her diagnosis as a result of "doing the responsible thing," she helps destigmatize the fear associated with cancer screenings. Her message is clear: early detection does not just save lives; it "saves normalcy." It allows patients to maintain their roles as parents, professionals, and athletes.
The Necessity of Culturally Competent Support
The success of Sharsheret highlights the need for specialized support groups that understand the cultural, religious, and genetic backgrounds of patients. For Ashman, being connected with women who shared her Jewish heritage and family values provided a level of comfort that general support groups might not have achieved.
Resilience Through Connection
Perhaps the most significant implication of Ashman’s journey is the validation of community as a therapeutic tool. In an era where medical treatment can feel clinical and isolating, the presence of a "sisterhood" provides a psychological buffer against the trauma of illness. Ashman’s family—including her mother, her father, and her sister, who is currently battling Stage 4 breast cancer—formed a domestic front of resilience that was bolstered by her external networks.
Conclusion: Playing the Game Together
Tori Ashman remains a vocal advocate for women’s health, urging others to schedule their mammograms without delay. Her journey from the Mamanet court to the oncology clinic and back again is a story of victory—not just over a disease, but over the isolation that often accompanies it.
"This experience taught me that true strength comes from community," Ashman reflects. "Together, we are strong. We are survivors. We are sisters. And none of us ever have to play this game alone."
As she continues her life—healthy, grateful, and active—her story stands as a reminder that while a diagnosis may be individual, the fight is collective. Through organizations like Sharsheret and the unwavering support of teammates, the path through cancer can be paved with laughter, light, and the enduring strength of a community in motion.
If you or someone you love has been impacted by breast or ovarian cancer, or if you want to learn more about your risk and the resources available, you can reach out to Sharsheret at [email protected] or visit their website for peer support and educational materials.
About the Author
